- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Oncology Practice Leaders Refocusing Efforts to Improve Long Term Viability
Oncology practices are experiencing acute challenges in today’s rapidly changing healthcare environment. Costs for treating patients are increasing, regulatory changes are affecting the way practices operate, and there are significant changes in reimbursement — compounded by a 2% reduction in fees as a result of the recent sequestration. In addition, payers are moving away from the traditional fee-for-service payment model towards value-based models that recognize quality and patient outcomes.
These shifts require practice leadership to make preserving or increasing revenue and cash flow a top priority. After all, practices cannot provide care if they cannot afford to stay in business. So, how should practice leaders re-tool and re-focus their efforts to keep their practices financially viable and thriving in these challenging times?
Read the full story here: http://bit.ly/YF6GpB
Source: OBROncology.com
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
